Browse Category

NYSE:LLY 8 June 2026 - 10 August 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

Eli Lilly (NYSE:LLY) gains $30 billion following UK approval for Foundayo; NHS access remains pending

Eli Lilly and Company’s Foundayo received approval in Britain for weight management and type 2 diabetes on Monday. Shares last traded at approximately $1,220, up 2.9%, as of 14:19 EDT, valuing the company near $1.09 trillion.

10 August 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Eli Lilly Q2 growth focus: Mounjaro and Zepbound seen as drivers for up to 98% of quarterly increase

Eli Lilly and Company is set for a tight earnings test on Wednesday. Initial projections indicate that Mounjaro and Zepbound will account for about 98% of the revenue increase in the second quarter.

5 August 2026

Earnings·NYSE:LLY·Pharmaceuticals·Stock Market

Novo Nordisk (CPH:NOVO-B; NYSE:NVO) ADR drops after Q2 results outpace forecasts, paving way for possible rebound in Copenhagen

Novo Nordisk’s U.S. ADR dropped 6.8% on Tuesday even after the company reported earnings that surpassed expectations. The decline indicates lingering investor doubts about the strength of its recovery.

4 August 2026

Earnings·NYSE:LLY·NYSE:NVO·Pharmaceuticals·Stock Market

AtaiBeckley Shares at $7.17 as Lilly Agreement Sets CVR at 42 Cents

Shares of AtaiBeckley Inc. remained flat at $7.17 as of 1 p.m. on Tuesday. This price stood 42 cents higher than Eli Lilly and Co.'s $6.75 cash offer at close.

28 July 2026

NASDAQ:ATAI·NYSE:LLY·Pharmaceuticals·Stock Market

AtaiBeckley (NASDAQ:ATAI) shares trade with Merger CVR valued near 19% of face

AtaiBeckley, previously known as Atai Life Sciences, closed at $7.22 on Friday, trading 47 cents higher than the cash element of Eli Lilly’s offer. U.S. stock markets did not open on Sunday.

19 July 2026

Biotechnology·NASDAQ:ATAI·NYSE:LLY·Stock Market

TrumpRx’s 800-Drug List Masks Modest Pharma Price Exposure

TrumpRx currently includes around 10% of the branded drug portfolios offered by pharmaceutical companies taking part in the program, well below the widely cited figure of more than 800 medicines.

17 July 2026

NASDAQ:GILD·NYSE:LLY·NYSE:PFE·Pharmaceuticals

Eli Lilly (NYSE:LLY) Shares Rise After Atai Partnership Could Unlock $1 Billion in Milestones

NEW YORK, July 16, 2026, 5:08 p.m. EDT – Shares of Eli Lilly edged higher on Thursday after the drugmaker announced a deal with Atai Life Sciences, a partnership that may generate up to $1 billion in milestone payments.

16 July 2026

NASDAQ:ATAI·NYSE:LLY·Pharmaceuticals·Stock Market

AtaiBeckley (NASDAQ: ATAI) stock jumps on Lilly deal as market discounts milestones

AtaiBeckley Inc. jumped about 31% to $7.04 on Thursday. Eli Lilly and Co. agreed to buy the company for up to $3.8 billion.

16 July 2026

NASDAQ:ATAI·NYSE:LLY·Pharmaceuticals·Stock Market

VivoSim Labs (NASDAQ:VIVS) hits $5M milestone; company says 500% revenue jump comes off $131K base

VivoSim Labs, Inc. reported Wednesday it got a $5 million milestone payment from Eli Lilly and Company, bringing in cash worth about 1.7 times VivoSim’s equity value at Tuesday’s close and recent share count. Still, shares ended up just 3.0% at $0.8599, slipping from an open of $1.49.

15 July 2026

Biotechnology·Nasdaq·NASDAQ:VIVS·NYSE:LLY·Stock Market

Eli Lilly (LLY) Hovers Near $1,200 as Focus Stays on $50 Obesity Drug Access

Eli Lilly grabbing headlines with its four-digit stock price and split plan, but there’s a messier reality for investors. The drugmaker is giving up higher net prices in order to sell a lot more units.

9 July 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Lilly (NYSE:LLY) closes holiday week near record as XLV outpaces

Eli Lilly and Company heads into the holiday-shortened week trading near its all-time highs. Last week, though, the more notable move wasn’t Lilly’s climb. Most of the buying in healthcare came from stocks outside of Lilly, even while it stayed the sector’s largest name.

4 July 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Centessa (NASDAQ:CNTA) marks Eli Lilly (NYSE:LLY) CVR at 28 cents per dollar in last trade

As of 10:03 a.m. in New York, U.S. regular trading was open, following Nasdaq’s 9:30 a.m. to 4 p.m. ET session, but Centessa Pharmaceuticals plc had no new trades. Nasdaq’s CNTA market page showed no data, with the last price still at $40.50 from June 24 UTC.

30 June 2026

Nasdaq·NASDAQ:CNTA·NYSE:LLY

Eli Lilly and Company (NYSE:LLY) stock nears Cantor target after $76 billion Friday pop

At 05:01 EDT, the New York Stock Exchange cash session had not opened. NYSE lists a 9:30 a.m. to 4:00 p.m. ET core session, and its 2026 holiday list shows the next full U.S. market closure is July 3 for Independence Day observed.

29 June 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Eli Lilly (NYSE:LLY) gains $76 billion in one day as Jaypirca headlines land

Eli Lilly and Company closed at $1,208.12 on Friday, up $80.43. Markets in U.S. cash equities were closed Saturday, leaving Friday as the last pricing. About 7.73 million shares traded, coming in at roughly 2.5 times the average volume listed on Google Finance.

27 June 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Eli Lilly (NYSE:LLY) move lifts healthcare ETF on Medicare GLP-1 signal

Eli Lilly and Company jumped 6.5% to $1,200.98 by 1:46 p.m. EDT Friday, tacking on about $65.7 billion in market cap. Shares hovered close to the session’s high of $1,208.18. The stock was at 42.7 times earnings, with 3.6 million shares traded.

26 June 2026

ETFs·NYSE:LLY·Pharmaceuticals·Stock Market

Centessa (NASDAQ:CNTA) final price leaves Lilly (NYSE:LLY) CVR at about 28% of max

Centessa Pharmaceuticals plc shares were not trading live on Friday, but this wasn’t due to a holiday. Trading in New York was open at 10:04 a.m. EDT, with the Nasdaq’s regular session running 9:30 a.m. to 4:00 p.m. ET. There’s no market closure for June 26 on the 2026 holiday list.

26 June 2026

NASDAQ:CNTA·NYSE:LLY·Pharmaceutical Industry·Stock Market

Novo Nordisk (CPH:NOVO-B) gains as South Africa copycat order tops Ozempic, Wegovy local sales

Novo Nordisk’s B shares jumped 2.6% to 307.75 Danish crowns on Tuesday. The stock is up 5.1% since Friday’s close and has gained 9.9% over three sessions. The OMXC25 index in Copenhagen fell 0.07%.

24 June 2026

NYSE:CVS·NYSE:LLY·NYSE:NVO·Pharmaceuticals·Stock Market

ARK picks up $52 million in Snowflake shares, bets on AI cloud

ARK Investment Management bought $52 million worth of Snowflake, pulling Cathie Wood back into a big AI software bet. The move comes under a month after the cloud data stock rallied on strong earnings and a major deal with Amazon Web Services.

21 June 2026

Artificial Intelligence·Cloud Computing·NASDAQ:AMZN·NASDAQ:ROKU·NASDAQ:TSLA·NYSE:LLY·NYSE:SNOW·Stock Market·Technology

Nasdaq Futures Rise Ahead of CPI; Tech Buyers Step In

Nasdaq futures climbed Tuesday morning, pulling U.S. stock futures higher as traders bought back into tech ahead of a major inflation reading that could challenge the recovery.

9 June 2026

NASDAQ:AAPL·NASDAQ:NVDA·NASDAQ:ORCL·NYSE:GS·NYSE:LLY·Stock Market·Technology

Eli Lilly Set for Key Monday After New Weight-Loss Drug Data

Eli Lilly heads into the U.S. pre-market Monday facing a fresh test of its trillion-dollar market cap after dropping new data on wider benefits from its upcoming obesity drugs. Shares ended Friday at $1,131.42, gaining 0.55%. The S&P 500 ETF lost 2.6%. The Health Care Select Sector SPDR ETF picked up 0.6% in the last quoted session.

8 June 2026

NYSE:LLY

1 2 3 … 14 Next

NYSE:LLY 8 June 2026 - 10 August 2026

Eli Lilly (NYSE:LLY) gains $30 billion following UK approval for Foundayo; NHS access remains pending

Eli Lilly Q2 growth focus: Mounjaro and Zepbound seen as drivers for up to 98% of quarterly increase

Novo Nordisk (CPH:NOVO-B; NYSE:NVO) ADR drops after Q2 results outpace forecasts, paving way for possible rebound in Copenhagen

AtaiBeckley Shares at $7.17 as Lilly Agreement Sets CVR at 42 Cents

AtaiBeckley (NASDAQ:ATAI) shares trade with Merger CVR valued near 19% of face

TrumpRx’s 800-Drug List Masks Modest Pharma Price Exposure

Eli Lilly (NYSE:LLY) Shares Rise After Atai Partnership Could Unlock $1 Billion in Milestones

AtaiBeckley (NASDAQ: ATAI) stock jumps on Lilly deal as market discounts milestones

VivoSim Labs (NASDAQ:VIVS) hits $5M milestone; company says 500% revenue jump comes off $131K base

Eli Lilly (LLY) Hovers Near $1,200 as Focus Stays on $50 Obesity Drug Access

Lilly (NYSE:LLY) closes holiday week near record as XLV outpaces

Centessa (NASDAQ:CNTA) marks Eli Lilly (NYSE:LLY) CVR at 28 cents per dollar in last trade

Eli Lilly and Company (NYSE:LLY) stock nears Cantor target after $76 billion Friday pop

Eli Lilly (NYSE:LLY) gains $76 billion in one day as Jaypirca headlines land

Eli Lilly (NYSE:LLY) move lifts healthcare ETF on Medicare GLP-1 signal

Centessa (NASDAQ:CNTA) final price leaves Lilly (NYSE:LLY) CVR at about 28% of max

Novo Nordisk (CPH:NOVO-B) gains as South Africa copycat order tops Ozempic, Wegovy local sales

ARK picks up $52 million in Snowflake shares, bets on AI cloud

Nasdaq Futures Rise Ahead of CPI; Tech Buyers Step In

Eli Lilly Set for Key Monday After New Weight-Loss Drug Data

TechStock² Updates

Beyond Meat Stock Slides 20% as BYND’s 1-for-30 Split Starts a 12-Session Nasdaq Test

Nebius Shares Rise 5% on NASDAQ, $2 Billion Revenue Target Sets Challenge for H2 Earnings

Joby Aviation (JOBY) Shares Drop as $500 Million Defense Contract Raises Funding Concerns

Firefly Aerospace Stock (FLY) Stalls as $106 Million Cash Burn Tests Record Revenue

Banco Bradesco Shares (BBD) Drop as Capital-Raise Pricing Rises Above Market Level

Top Stock Picks

Taiwan Semiconductor

AerCap

Constellation Energy

Walt Disney

American International Group

Live updates

Investment Disclaimer